CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Viromed Company Ltd Company Snapshot
Viromed Company Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Viromed Company Ltd with three other companies in this sector in South Korea: Eu Biologics Co Ltd (2016 sales of 4.84 billion Korean Won [US$4.33 million] ), Tego Science Inc (8.34 billion Korean Won [US$7.46 million] ), and Alteogen Inc (6.84 billion Korean Won [US$6.12 million] ).

Sales Analysis. During the year ended December of 2016, sales at Viromed Company Ltd were 6.84 billion Korean Won (US$6.12 million). This is a decrease of 11.1% versus 2015, when the company's sales were 7.70 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Viromed Company Ltd
  Stock Performance Chart for Viromed Company Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 103,100
(Figures in Korean Won)
1 Week -1.8%   13 Weeks -3.9%  
4 Weeks 9.0%   52 Weeks -15.3%  
 
Viromed Company Ltd Key Data:
  Ticker: 084990 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 6,844,031,524
(Year Ending Jan 2017).
Employees: 57
  Currency: Korean Won Market Cap: 1,645,090,406,000
  Fiscal Yr Ends: December Shares Outstanding: 15,956,260
  Share Type: Common Closely Held Shares: 2,779,227
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.